BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32895341)

  • 1. [The Incidences of Catheter Colonization and Central Line-Associated Bloodstream Infection According to Tegaderm vs. Chlorhexidine Gluconate (CHG)-Tegaderm Dressing].
    Kim E; Lee H
    J Korean Acad Nurs; 2020 Aug; 50(4):541-553. PubMed ID: 32895341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
    Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
    Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
    Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
    Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing bloodstream infection with a chlorhexidine gel IV dressing.
    Jeanes A; Bitmead J
    Br J Nurs; 2015 Oct 22-Nov 11; 24(19):S14-9. PubMed ID: 26496869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tegaderm CHG IV Securement Dressing for Central Venous and Arterial Catheter Insertion Sites: A NICE Medical Technology Guidance.
    Jenks M; Craig J; Green W; Hewitt N; Arber M; Sims A
    Appl Health Econ Health Policy; 2016 Apr; 14(2):135-49. PubMed ID: 26458938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients.
    Righetti M; Palmieri N; Bracchi O; Prencipe M; Bruschetta E; Colombo F; Brenna I; Stefani F; Amar K; Scalia A; Conte F
    J Vasc Access; 2016 Sep; 17(5):417-422. PubMed ID: 27516139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years.
    Eggimann P; Pagani JL; Dupuis-Lozeron E; Ms BE; Thévenin MJ; Joseph C; Revelly JP; Que YA
    Intensive Care Med; 2019 Jun; 45(6):823-833. PubMed ID: 30997542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial.
    Chan RJ; Northfield S; Larsen E; Mihala G; Ullman A; Hancock P; Marsh N; Gavin N; Wyld D; Allworth A; Russell E; Choudhury MA; Flynn J; Rickard CM
    Trials; 2017 Oct; 18(1):458. PubMed ID: 28978332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in microorganism growth on various dressings used to cover injection sites: inspection of the risk of catheter-related bloodstream infections caused by Gram-negative bacilli.
    Kawamura H; Takahashi N; Takahashi M; Taketomi A
    Surg Today; 2014 Dec; 44(12):2339-44. PubMed ID: 24871954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlorhexidine gluconate or polyhexamethylene biguanide disc dressing to reduce the incidence of central-line-associated bloodstream infection: a feasibility randomized controlled trial (the CLABSI trial).
    Webster J; Larsen E; Marsh N; Choudhury A; Harris P; Rickard CM
    J Hosp Infect; 2017 Jul; 96(3):223-228. PubMed ID: 28526171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative evaluation of antimicrobial coated versus nonantimicrobial coated peripherally inserted central catheters on associated outcomes: A randomized controlled trial.
    Storey S; Brown J; Foley A; Newkirk E; Powers J; Barger J; Paige K
    Am J Infect Control; 2016 Jun; 44(6):636-41. PubMed ID: 27240799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients.
    Thokala P; Arrowsmith M; Poku E; Martyn-St James M; Anderson J; Foster S; Elliott T; Whitehouse T
    J Infect Prev; 2016 Sep; 17(5):216-223. PubMed ID: 27582899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorhexidine gluconate dressings reduce bacterial colonization rates in epidural and peripheral regional catheters.
    Kerwat K; Eberhart L; Kerwat M; Hörth D; Wulf H; Steinfeldt T; Wiesmann T
    Biomed Res Int; 2015; 2015():149785. PubMed ID: 25879016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy of three topical antiseptic solutions for the prevention of catheter colonization: a multicenter randomized controlled study.
    Yasuda H; Sanui M; Abe T; Shime N; Komuro T; Hatakeyama J; Matsukubo S; Kawano S; Yamamoto H; Andoh K; Seo R; Inoue K; Noda E; Saito N; Nogami S; Okamoto K; Fuke R; Gushima Y; Kobayashi A; Takebayashi T; Lefor AK;
    Crit Care; 2017 Dec; 21(1):320. PubMed ID: 29268759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
    Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
    Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a chlorhexidine intravascular catheter gel dressing on short-term central venous catheters.
    Karpanen TJ; Casey AL; Whitehouse T; Nightingale P; Das I; Elliott TS
    Am J Infect Control; 2016 Jan; 44(1):54-60. PubMed ID: 26455868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
    Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
    JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorhexidine-impregnated transparent dressings decrease catheter-related infections in hemodialysis patients: a quality improvement project.
    Apata IW; Hanfelt J; Bailey JL; Niyyar VD
    J Vasc Access; 2017 Mar; 18(2):103-108. PubMed ID: 28165583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
    Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
    J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Activity of a Novel Vascular Access Film Dressing Containing Chlorhexidine Gluconate.
    Wibaux A; Thota P; Mastej J; Prince DL; Carty N; Johnson P
    PLoS One; 2015; 10(11):e0143035. PubMed ID: 26599087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.